The groundbreaking rise of Viagra has long been a example of pharmaceutical success, yet its position within the broader sector now raises questions about long-term yields . Alternative versions are eroding market share, causing concerns that betting on companies closely tied to Viagra's former position could be a dangerous move , especially given